RC
ZURA icon

RBF Capital’s Zura Bio ZURA Stock Holding History

RBF Capital’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$346K Sell
58,193
-10,000
-15% -$60.4K 0.02% 405
2025
Q4 		$357K Sell
68,193
-11,807
-15% -$46.7K 0.02% 453
2025
Q3 		$346K Sell
80,000
-40,000
-33% -$71.9K 0.02% 447
2025
Q2 		$126K Buy
+120,000
New +$143K 0.01% 558

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

RBF Capital's ZURA Position: Q1 2026 in Review

RBF Capital reduced its Zura Bio (ZURA) stake by 15% in Q1 2026, selling an estimated $60.4K and leaving 58,193 shares worth $346K. The position accounts for 0.02% of the portfolio, ranked #405.

RBF Capital first reported a position in ZURA in Q2 2025 and has held it in 4 quarters since. The position peaked at $357K in Q4 2025. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • RBF Capital held 58,193 shares of Zura Bio worth $346K as of Q1 2026.
  • RBF Capital sold 10,000 Zura Bio shares in Q1 2026, an estimated $60.4K.
  • Zura Bio made up 0.02% of RBF Capital's portfolio in Q1 2026, its #405 holding.
  • RBF Capital first reported a position in Zura Bio in Q2 2025 and has held it in 4 quarters since.
  • RBF Capital's Zura Bio position peaked at $357K in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on RBF Capital's 13F filing for Q1 2026, filed 15 May 2026.